IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis
Tuberculosis (TB) is the oldest and most deadly disease in human history, causing over 1.2 million deaths every year. TB is an infectious airborne disease that mainly affects the lungs. It is caused by the bacterium Mycobacterium tuberculosis (Mtb).The main treatment option for TB is long courses of multiple antibiotics. However antimicrobial resistance (AMR) – a process in which bacteria have developed the ability to resist the action of medicines…